Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
A Noy, H Schöder, M Gönen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease
A Younes, F Cabanillas, P W McLaughlin, et al.
Investigational New Drugs
|
May 1, 1991
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas
J P Crown, S Gulati, D J Straus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients
H M Golomb, A Jacobs, A Fefer, et al.
Tree Physiology
|
April 1, 1997
Growth and water relations of Eucalyptus marginata (jarrah) stands in response to thinning and fertilization
G L Stoneman, D S Crombie, K Whitford, et al.
Seminars in Oncology
|
October 1, 1988
Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b
H M Golomb, A Fefer, D W Golde, et al.
Journal of the National Cancer Institute
|
May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia
H M Golomb, M J Ratain, A Fefer, et al.
Seminars in Oncology
|
June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia
H M Golomb, A Fefer, D W Golde, et al.
Seminars in Oncology
|
June 1, 1987
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma
R D Leavitt, V Ratanatharathorn, H Ozer, et al.
The New England Journal of Medicine
|
July 14, 1994
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
K Offit, F Lo Coco, D C Louie, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)
A Noy, H Schöder, M Gönen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Preliminary experience with paclitaxel for the treatment of relapsed and refractory Hodgkin's disease
A Younes, F Cabanillas, P W McLaughlin, et al.
Investigational New Drugs
|
May 1, 1991
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas
J P Crown, S Gulati, D J Straus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients
H M Golomb, A Jacobs, A Fefer, et al.
Tree Physiology
|
April 1, 1997
Growth and water relations of Eucalyptus marginata (jarrah) stands in response to thinning and fertilization
G L Stoneman, D S Crombie, K Whitford, et al.
Seminars in Oncology
|
October 1, 1988
Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b
H M Golomb, A Fefer, D W Golde, et al.
Journal of the National Cancer Institute
|
May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia
H M Golomb, M J Ratain, A Fefer, et al.
Seminars in Oncology
|
June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia
H M Golomb, A Fefer, D W Golde, et al.
Seminars in Oncology
|
June 1, 1987
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma
R D Leavitt, V Ratanatharathorn, H Ozer, et al.
The New England Journal of Medicine
|
July 14, 1994
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
K Offit, F Lo Coco, D C Louie, et al.
Page
of 3